Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

April 01, 2004; Volume 32,Issue 4

Symposium Article

  • You have access
    TRANSCRIPTIONAL SUPPRESSION OF CYTOCHROME P450 GENES BY ENDOGENOUS AND EXOGENOUS CHEMICALS
    David S. Riddick, Chunja Lee, Anahita Bhathena, Yoav E. Timsit, Po-Yung Cheng, Edward T. Morgan, Russell A. Prough, Sharon L. Ripp, Kristy K. Michael Miller, Asmeen Jahan and John Y. L. Chiang
    Drug Metabolism and Disposition April 2004, 32 (4) 367-375; DOI: https://doi.org/10.1124/dmd.32.4.367

Short Communications

  • You have access
    CLONING CYP2D21 AND CYP3A22 CDNAS FROM LIVER OF MINIATURE PIGS
    Tsutomu Sakuma, Tsukasa Shimojima, Kiyoshi Miwa and Tetsuya Kamataki
    Drug Metabolism and Disposition April 2004, 32 (4) 376-378; DOI: https://doi.org/10.1124/dmd.32.4.376
  • You have access
    IDENTIFICATION OF HUMAN CYTOCHROME P450 2D6 AS MAJOR ENZYME INVOLVED IN THE O-DEMETHYLATION OF THE DESIGNER DRUG P-METHOXYMETHAMPHETAMINE
    Roland F. Staack, Denis S. Theobald, Liane D. Paul, Dietmar Springer, Thomas Kraemer and Hans H. Maurer
    Drug Metabolism and Disposition April 2004, 32 (4) 379-381; DOI: https://doi.org/10.1124/dmd.32.4.379
  • You have access
    A PROTEOMIC APPROACH TO THE IDENTIFICATION OF CYTOCHROME P450 ISOFORMS IN MALE AND FEMALE RAT LIVER BY NANOSCALE LIQUID CHROMATOGRAPHY-ELECTROSPRAY IONIZATION-TANDEM MASS SPECTROMETRY
    S. Nisar, C. S. Lane, A. F. Wilderspin, K. J. Welham, W. J. Griffiths and L. H. Patterson
    Drug Metabolism and Disposition April 2004, 32 (4) 382-386; DOI: https://doi.org/10.1124/dmd.32.4.382

Articles

  • You have access
    NEW METABOLIC PATHWAYS FOR FLAVANONES CATALYZED BY RAT LIVER MICROSOMES
    Dejan Nikolic and Richard B. van Breemen
    Drug Metabolism and Disposition April 2004, 32 (4) 387-397; DOI: https://doi.org/10.1124/dmd.32.4.387
  • You have access
    COMPARISON OF PREDICTION METHODS FOR IN VIVO CLEARANCE OF (S,S)-3-[3-(METHYLSULFONYL)PHENYL]-1-PROPYLPIPERIDINE HYDROCHLORIDE, A DOPAMINE D2 RECEPTOR ANTAGONIST, IN HUMANS
    Shinji Yamazaki, Lisa N. Toth, Meredith L. Black and J. Neil Duncan
    Drug Metabolism and Disposition April 2004, 32 (4) 398-404; DOI: https://doi.org/10.1124/dmd.32.4.398
  • You have access
    HEPATOBILIARY EXCRETION OF BERBERINE
    Pi-Lo Tsai and Tung-Hu Tsai
    Drug Metabolism and Disposition April 2004, 32 (4) 405-412; DOI: https://doi.org/10.1124/dmd.32.4.405
  • You have access
    HUMAN UDP-GLUCURONOSYLTRANSFERASES: ISOFORM SELECTIVITY AND KINETICS OF 4-METHYLUMBELLIFERONE AND 1-NAPHTHOL GLUCURONIDATION, EFFECTS OF ORGANIC SOLVENTS, AND INHIBITION BY DICLOFENAC AND PROBENECID
    Verawan Uchaipichat, Peter I. Mackenzie, Xiao-Hui Guo, Dione Gardner-Stephen, Aleksandra Galetin, J. Brian Houston and John O. Miners
    Drug Metabolism and Disposition April 2004, 32 (4) 413-423; DOI: https://doi.org/10.1124/dmd.32.4.413
  • You have access
    EXPRESSION STUDIES AND FUNCTIONAL CHARACTERIZATION OF RENAL HUMAN ORGANIC ANION TRANSPORTER 1 ISOFORMS
    Andrew Bahn, Christian Ebbinghaus, Diana Ebbinghaus, Evgeni G. Ponimaskin, Laszlo Fuzesï, Gerhard Burckhardt and Yohannes Hagos
    Drug Metabolism and Disposition April 2004, 32 (4) 424-430; DOI: https://doi.org/10.1124/dmd.32.4.424
  • You have access
    ASSESSMENT OF ARGININE 97 AND LYSINE 72 AS DETERMINANTS OF SUBSTRATE SPECIFICITY IN CYTOCHROME P450 2C9 (CYP2C9)
    Carwyn Davies, Katey Witham, Justin R. Scott, Andrew Pearson, James J. DeVoss, Sandra E. Graham and Elizabeth M. J. Gillam
    Drug Metabolism and Disposition April 2004, 32 (4) 431-436; DOI: https://doi.org/10.1124/dmd.32.4.431
  • You have access
    ENDOTOXIN-MEDIATED DISTURBANCE OF HEPATIC CYTOCHROME P450 FUNCTION AND DEVELOPMENT OF ENDOTOXIN TOLERANCE IN THE RAT MODEL OF DEXTRAN SULFATE SODIUM-INDUCED EXPERIMENTAL COLITIS
    Yasuhiro Masubuchi and Toshiharu Horie
    Drug Metabolism and Disposition April 2004, 32 (4) 437-441; DOI: https://doi.org/10.1124/dmd.32.4.437
  • You have access
    INCORPORATION OF AN OXYGEN FROM WATER INTO TROGLITAZONE QUINONE BY CYTOCHROME P450 AND MYELOPEROXIDASE
    Kan He, Rasmy E. Talaat and Thomas F. Woolf
    Drug Metabolism and Disposition April 2004, 32 (4) 442-446; DOI: https://doi.org/10.1124/dmd.32.4.442
  • You have access
    QUANTITATIVE CONTRIBUTION OF CYP2D6 AND CYP3A TO OXYCODONE METABOLISM IN HUMAN LIVER AND INTESTINAL MICROSOMES
    Bojan Lalovic, Brian Phillips, Linda L. Risler, William Howald and Danny D. Shen
    Drug Metabolism and Disposition April 2004, 32 (4) 447-454; DOI: https://doi.org/10.1124/dmd.32.4.447
  • You have access
    AMINO ACID RESIDUE ILE211 IS ESSENTIAL FOR THE ENZYMATIC ACTIVITY OF HUMAN UDP-GLUCURONOSYLTRANSFERASE 1A10 (UGT1A10)
    Isabelle Martineau, André Tchernof and Alain Bélanger
    Drug Metabolism and Disposition April 2004, 32 (4) 455-459; DOI: https://doi.org/10.1124/dmd.32.4.455
  • You have access
    THE EFFECT OF CIMETIDINE ON DEXTROMETHORPHAN O-DEMETHYLASE ACTIVITY OF HUMAN LIVER MICROSOMES AND RECOMBINANT CYP2D6
    Maria Madeira, Marc Levine, Thomas K. H. Chang, Ahmad Mirfazaelian and Gail D. Bellward
    Drug Metabolism and Disposition April 2004, 32 (4) 460-467; DOI: https://doi.org/10.1124/dmd.32.4.460
  • You have access
    KEY STRUCTURAL FEATURES OF LIGANDS FOR ACTIVATION OF HUMAN PREGNANE X RECEPTOR
    Kaoru Kobayashi, Saeko Yamagami, Tomoaki Higuchi, Masakiyo Hosokawa and Kan Chiba
    Drug Metabolism and Disposition April 2004, 32 (4) 468-472; DOI: https://doi.org/10.1124/dmd.32.4.468
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 32 (4)
Drug Metabolism and Disposition
Vol. 32, Issue 4
1 Apr 2004
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • Symposium Article
  • Short Communications
  • Articles
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics